TRACY HAGAN: Open Payments
NPI 1558324715 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,322 in 62 payments from 20 companies in 2025. Trend: 2023 $1,105 · 2024 $1,257 · 2025 $1,322
Food & beverage: $1,223Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $204 |
| Merck Sharp & Dohme LLC | 9 | $161 |
| PFIZER INC. | 10 | $161 |
| AstraZeneca Pharmaceuticals LP | 5 | $106 |
| Daiichi Sankyo Inc. | 4 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $91 |
| Celgene Corporation | 4 | $86 |
| Janssen Biotech, Inc. | 3 | $62 |
| Genentech USA, Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
Products named: VENCLEXTA, KEYTRUDA, REBLOZYL, IBRANCE, ICLUSIG, DATROWAY, PLUVICTO, ENHERTU.
Industry payments across KY — which companies pay providers there.
